News Shortcuts from other journals

Combined antihypertensive may not be as good as it looks for type 2 diabetes

BMJ 2007; 335 doi: (Published 13 September 2007) Cite this as: BMJ 2007;335:536

A large international trial reports that a fixed combination of the angiotensin converting enzyme (ACE) inhibitor perindopril and the diuretic indapamide protects people with type 2 diabetes from cardiovascular disease and microvascular complications (combined hazard ratio 0.91, 95% CI 0.83 to 1.00, P=0.04) and …

View Full Text

Log in

Log in through your institution


* For online subscription